These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 8307609

  • 1. Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.
    Hajeer AH, Snowden N, Wilson P, Drover S, Ollier WE.
    Immunology; 1993 Dec; 80(4):593-7. PubMed ID: 8307609
    [Abstract] [Full Text] [Related]

  • 2. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
    Grosjean I, Lachaux A, Bella C, Aubry JP, Bonnefoy JY, Kaiserlian D.
    Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
    [Abstract] [Full Text] [Related]

  • 3. T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
    Torsteinsdottir S, Masucci MG, Szigeti R, Bishara A, Brautbar C, Klein G, Klein E.
    Mol Biol Med; 1984 Aug; 2(4):285-99. PubMed ID: 6443579
    [Abstract] [Full Text] [Related]

  • 4. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses.
    Flores-Romo L, Johnson GD, Ghaderi AA, Stanworth DR, Veronesi A, Gordon J.
    Eur J Immunol; 1990 Nov; 20(11):2465-9. PubMed ID: 2147649
    [Abstract] [Full Text] [Related]

  • 5. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
    Altomonte M, Pucillo C, Damante G, Maio M.
    J Immunol; 1993 Nov 15; 151(10):5115-22. PubMed ID: 8228213
    [Abstract] [Full Text] [Related]

  • 6. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
    Szöllósi J, Horejsí V, Bene L, Angelisová P, Damjanovich S.
    J Immunol; 1996 Oct 01; 157(7):2939-46. PubMed ID: 8816400
    [Abstract] [Full Text] [Related]

  • 7. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H, Spindeldreher S, Röhn TA, Platania N, Grygar C, Daniel N, Wölpl A, Langen H, Horejsi V, Vogt AB.
    Nat Immunol; 2002 Jan 01; 3(1):61-8. PubMed ID: 11743588
    [Abstract] [Full Text] [Related]

  • 8. Cross-linking of MHC class II molecules interferes with phorbol 12,13-dibutyrate-induced differentiation of resting B cells by inhibiting Rac-associated ROS-dependent ERK/p38 MAP kinase pathways leading to NF-kappaB activation.
    Yang HY, Kim J, Chung GH, Lee JC, Jang YS.
    Mol Immunol; 2007 Mar 01; 44(7):1577-86. PubMed ID: 17011624
    [Abstract] [Full Text] [Related]

  • 9. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
    Drénou B, Blancheteau V, Burgess DH, Fauchet R, Charron DJ, Mooney NA.
    J Immunol; 1999 Oct 15; 163(8):4115-24. PubMed ID: 10510346
    [Abstract] [Full Text] [Related]

  • 10. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
    Hatakeyama N, Tamura Y, Sahara H, Suzuki N, Suzuki K, Hori T, Mizue N, Torigoe T, Tsutsumi H, Sato N.
    Exp Hematol; 2006 Feb 15; 34(2):197-207. PubMed ID: 16459188
    [Abstract] [Full Text] [Related]

  • 11. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
    Sugano M, Conway TF, Kelleher RJ, Sugiyama Y, Chen FA, Bankert RB, Bernstein SH.
    J Exp Clin Cancer Res; 2001 Jun 15; 20(2):175-82. PubMed ID: 11484971
    [Abstract] [Full Text] [Related]

  • 12. Alloantigen presentation by B cells: analysis of the requirement for B-cell activation.
    Wilson JL, Cunningham AC, Kirby JA.
    Immunology; 1995 Nov 15; 86(3):325-30. PubMed ID: 8550066
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion.
    Knox PG, Young LS.
    Virology; 1995 Oct 20; 213(1):147-57. PubMed ID: 7483258
    [Abstract] [Full Text] [Related]

  • 14. [MHC tetramers: tracking specific immunity].
    Kosor E, Gagro A, Drazenović V, Kuzman I, Jeren T, Rakusić S, Rabatić S, Markotić A, Gotovac K, Sabioncello A, Cecuk E, Kerhin-Brkljacić V, Gjenero-Margan I, Kaić B, Mlinarić-Galinović G, Kastelan A, Dekaris D.
    Acta Med Croatica; 2003 Oct 20; 57(4):255-9. PubMed ID: 14639858
    [Abstract] [Full Text] [Related]

  • 15. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
    Schnare M, Blum H, Jüttner S, Röllinghoff M, Gessner A.
    J Immunol; 1998 Oct 01; 161(7):3484-92. PubMed ID: 9759868
    [Abstract] [Full Text] [Related]

  • 16. B cell activation regulates exosomal HLA production.
    Arita S, Baba E, Shibata Y, Niiro H, Shimoda S, Isobe T, Kusaba H, Nakano S, Harada M.
    Eur J Immunol; 2008 May 01; 38(5):1423-34. PubMed ID: 18425730
    [Abstract] [Full Text] [Related]

  • 17. Growth inhibition of Epstein-Barr virus-transformed B cells by anti-HLA-DR antibody L243: possible relationship to L243-induced down-regulation of CD23 antigen expression.
    Kabelitz D, Janssen O.
    Cell Immunol; 1989 Apr 15; 120(1):21-30. PubMed ID: 2467753
    [Abstract] [Full Text] [Related]

  • 18. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
    Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F.
    Eur J Immunol; 2003 Jan 15; 33(1):125-34. PubMed ID: 12594841
    [Abstract] [Full Text] [Related]

  • 19. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z, Hofgaard PO, Omholt H, Bogen B.
    Scand J Immunol; 2004 Jan 15; 60(1-2):143-52. PubMed ID: 15238083
    [Abstract] [Full Text] [Related]

  • 20. Triggering of HLA-DR antigens differentially modulates tumor necrosis factor alpha release by B cells at distinct stage of maturation.
    Coral S, Pucillo C, Leonardi A, Fonsatti E, Altomonte M, Maio M.
    Cell Growth Differ; 1997 May 15; 8(5):581-8. PubMed ID: 9149909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.